Ligand Pharmaceuticals recently announced that CEO Todd Davis and CFO Tavo Espinoza will attend three major healthcare investor conferences in November 2025, including the UBS Global Healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback